Noel G Faux
Noel G Faux
Melbourne Data Analytics Platform - The University of Melbourne
Verified email at - Homepage
Cited by
Cited by
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
EM Moore, AG Mander, D Ames, MA Kotowicz, RP Carne, H Brodaty, ...
Diabetes care 36 (10), 2981-2987, 2013
Blood-based protein biomarkers for diagnosis of Alzheimer disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of neurology 69 (10), 1318-1325, 2012
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses
NG Faux, CW Ritchie, A Gunn, A Rembach, A Tsatsanis, J Bedo, ...
Journal of Alzheimer's Disease 20 (2), 509-516, 2010
A common fold mediates vertebrate defense and bacterial attack
CJ Rosado, AM Buckle, RHP Law, RE Butcher, WT Kan, CH Bird, K Ung, ...
Science 317 (5844), 1548-1551, 2007
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop
G Fenalti, RHP Law, AM Buckle, C Langendorf, K Tuck, CJ Rosado, ...
Nature structural & molecular biology 14 (4), 280-286, 2007
Functional insights from the distribution and role of homopeptide repeat-containing proteins
NG Faux, SP Bottomley, AM Lesk, JA Irving, JR Morrison, ...
Genome research 15 (4), 537-551, 2005
Larger temporal volume in elderly with high versus low beta-amyloid deposition
G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ...
Brain 133 (11), 3349-3358, 2010
Plasma amyloid-β as a biomarker in Alzheimer's disease: the AIBL study of aging
JK Lui, SM Laws, QX Li, VL Villemagne, D Ames, B Brown, AI Bush, ...
Journal of Alzheimer's disease 20 (4), 1233-1242, 2010
Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study
G Sittironnarit, D Ames, AI Bush, N Faux, L Flicker, J Foster, S Hilmer, ...
Dementia and geriatric cognitive disorders 31 (3), 173-178, 2011
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
A Rembach, NG Faux, AD Watt, KK Pertile, RL Rumble, BO Trounson, ...
Alzheimer's & Dementia 10 (1), 53-61, 2014
An anemia of Alzheimer's disease
NG Faux, A Rembach, J Wiley, KA Ellis, D Ames, CJ Fowler, RN Martins, ...
Molecular psychiatry 19 (11), 1227-1234, 2014
Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease
G Verdile, SM Laws, D Henley, D Ames, AI Bush, KA Ellis, NG Faux, ...
Molecular psychiatry 19 (1), 69-75, 2014
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ...
Molecular psychiatry 19 (4), 519-526, 2014
Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts
EM Moore, D Ames, AG Mander, RP Carne, H Brodaty, MC Woodward, ...
Journal of Alzheimer's Disease 39 (3), 661-668, 2014
Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian …
NG Faux, KA Ellis, L Porter, CJ Fowler, SM Laws, RN Martins, KK Pertile, ...
Journal of Alzheimer's Disease 27 (4), 909-922, 2011
Blood-borne amyloid-β dimer correlates with clinical markers of Alzheimer's disease
VL Villemagne, KA Perez, KE Pike, WM Kok, CC Rowe, AR White, ...
Journal of Neuroscience 30 (18), 6315-6322, 2010
Decreased plasma iron in Alzheimer’s disease is due to transferrin desaturation
DJ Hare, JD Doecke, NG Faux, A Rembach, I Volitakis, CJ Fowler, ...
ACS chemical neuroscience 6 (3), 398-402, 2015
CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord
JB Hilton, SW Mercer, NKH Lim, NG Faux, G Buncic, JS Beckman, ...
Scientific reports 7 (1), 42292, 2017
Association of cerebrospinal fluid ferritin level with preclinical cognitive decline in APOE-ε4 carriers
S Ayton, NG Faux, AI Bush
JAMA neurology 74 (1), 122-125, 2017
The system can't perform the operation now. Try again later.
Articles 1–20